{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:09:20Z","timestamp":1790809760356,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T00:00:00Z","timestamp":1404345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s10067-014-2735-7","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T09:27:36Z","timestamp":1404293256000},"page":"1279-1283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence of primary hyperparathyroidism in a referred sample of fibromyalgia patients"],"prefix":"10.1007","volume":"34","author":[{"given":"Robert","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony Science","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,3]]},"reference":[{"key":"2735_CR1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser WD (2009) Hyperparathyroidism. Lancet 374:145\u2013158","journal-title":"Lancet"},{"key":"2735_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4137\/CMED.S13147","volume":"6","author":"C Eufrazino","year":"2013","unstructured":"Eufrazino C, Veras A, Bandeira F (2013) Epidemiology of primary hyperparathyroidism and its non-classical manifestations in the City of Recife, Brazil. Clin Med Insights Endocrinol Diabetes 6:69\u201374","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"2735_CR3","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1210\/jc.2013-1300","volume":"98","author":"NE Cusano","year":"2013","unstructured":"Cusano NE, Maalouf NM, Wang PY, Zhang C, Cremers SC, Haney EM, Bauer DC, Orwoll ES, Bilezikian JP (2013) Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J Clin Endocrinol Metab 98:2734\u20132741","journal-title":"J Clin Endocrinol Metab"},{"key":"2735_CR4","first-page":"1029","volume":"36","author":"M Blackburn","year":"2007","unstructured":"Blackburn M, Diamond T (2007) Primary hyperparathyroidism and familial hyperparathyroid syndromes. Aust Fam Phys 36:1029\u20131033","journal-title":"Aust Fam Phys"},{"key":"2735_CR5","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","volume":"365","author":"C Marcocci","year":"2011","unstructured":"Marcocci C, Cetani F (2011) Clinical practice. Primary hyperparathyroidism. N Engl J Med 365:2389\u20132397","journal-title":"N Engl J Med"},{"key":"2735_CR6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.otc.2010.01.009","volume":"43","author":"EA Felger","year":"2010","unstructured":"Felger EA, Kandil E (2010) Primary hyperparathyroidism. Otolaryngol Clin North Am 43:417\u2013432","journal-title":"Otolaryngol Clin North Am"},{"key":"2735_CR7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/pgmj.59.690.236","volume":"59","author":"M Helliwell","year":"1983","unstructured":"Helliwell M (1983) Rheumatic symptoms in primary hyperparathyroidism. Postgrad Med J 59:236\u2013240","journal-title":"Postgrad Med J"},{"key":"2735_CR8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11926-002-0014-0","volume":"4","author":"MR Rubin","year":"2002","unstructured":"Rubin MR, Silverberg SJ (2002) Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy. Curr Rheumatol Rep 4:179\u2013185","journal-title":"Curr Rheumatol Rep"},{"key":"2735_CR9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0002-9343(89)80613-8","volume":"87","author":"SA Turken","year":"1989","unstructured":"Turken SA, Cafferty M, Silverberg SJ, De La Cruz L, Cimino C, Lange DJ et al (1989) Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. Am J Med 87:553\u2013557","journal-title":"Am J Med"},{"key":"2735_CR10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jocd.2012.12.001","volume":"16","author":"NE Cusano","year":"2013","unstructured":"Cusano NE, Silverberg SJ, Bilezikian JP (2013) Normocalcemic primary hyperparathyroidism. J Clin Densitometr 16:33\u201339","journal-title":"J Clin Densitometr"},{"key":"2735_CR11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198001243020402","volume":"302","author":"H Heath III","year":"1980","unstructured":"Heath H III, Hodgson SF, Kennedy M (1980) Primary hyperparathyroidism: incidence, morbidity and potential economic impact in a community. N Engl J Med 302:189\u2013193","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"2735_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jbmr.5650061409","volume":"6","author":"LJ Melton III","year":"1991","unstructured":"Melton LJ III (1991) Epidemiology of primary hyperparathyroidism. J Bone Miner Res Suppl 6(Suppl 2):25\u201330","journal-title":"J Bone Miner Res Suppl"},{"key":"2735_CR13","first-page":"194","volume-title":"Recent advances in endocrinology& metabolism (No. I)","author":"JLH O\u2019Riordan","year":"1978","unstructured":"O\u2019Riordan JLH (1978) Hormonal control of mineral metabolism. In: O\u2019Riordan JLH (ed) Recent advances in endocrinology& metabolism (No. I). Churchill Livingstone, Edinburgh, p 194"},{"key":"2735_CR14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0039-6060(97)90357-3","volume":"121","author":"E Lundgren","year":"1997","unstructured":"Lundgren E, Rastad J, Thurfjell E, Akerstrom G, Ljunghall S (1997) Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 121:287\u2013294","journal-title":"Surgery"},{"key":"2735_CR15","first-page":"1","volume":"820","author":"E Lundgren","year":"1999","unstructured":"Lundgren E (1999) Primary hyperparathyroidism of postmenopausal females. Prospective case\u2013control analysis on prevalence, clinical characteristics and treatment. Compr Sum Upps Fac Med 820:1\u201351","journal-title":"Compr Sum Upps Fac Med"},{"key":"2735_CR16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3109\/02813439209014060","volume":"10","author":"G Lindstedt","year":"1992","unstructured":"Lindstedt G, Nystrom E, Lundberg P-A, Johansson E, Eggertsen R (1992) Screening of an elderly population in primary care for primary hyperparathyroidism. Scand J Prim Health Care 10:192\u2013197","journal-title":"Scand J Prim Health Care"},{"key":"2735_CR17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2796.1992.tb00540.x","volume":"231","author":"A Sorva","year":"1992","unstructured":"Sorva A, Valvanne J, Tilvis RS (1992) Serum ionized calciumand the prevalence of primary hyperparathyroidism in age cohorts of 75, 80 and 85\u00a0years. J Intern Med 231:309\u2013312.1","journal-title":"J Intern Med"},{"key":"2735_CR18","unstructured":"Tsoukas M, Ste-Marie PA, Shir Y, Fitzcharles MA, Mitmaker E. URL: https:\/\/ww2.rheumatology.org\/apps\/MyAnnualMeeting\/Abstract\/37362"},{"key":"2735_CR19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P et al (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62:600\u2013610","journal-title":"Arthritis Care Res"},{"issue":"Suppl 2","key":"2735_CR20","first-page":"N18","volume":"17","author":"S Adami","year":"2002","unstructured":"Adami S, Marcocci C, Gatti D (2002) Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 17(Suppl 2):N18\u2013N23","journal-title":"J Bone Miner Res"},{"key":"2735_CR21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","volume":"94","author":"JP Bilezikian","year":"2009","unstructured":"Bilezikian JP, Khan A, Potts JT Jr (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop. J Clin Endocrinol Metab 94:335\u2013339","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2735-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2735-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2735-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T17:39:32Z","timestamp":1716917972000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2735-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,3]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["2735"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2735-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,3]]}}}